Rekvina Laboratories Share Price Today | Stock Price & Rekvina Laboratories Share Screener

Track the current stock price of Rekvina Laboratories with an interactive chart. Analyse VINRKLB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Rekvina Laboratories stock quote in one place.

The quote of ₹50.50 sits between the 52-week low of ₹7.08 and the 52-week high of ₹59.40, and the latest session moved 1.28% from the previous close.

Screen Rekvina Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VINRKLB shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE092O01028.

Classification

Identifiers and Leadership

Screen VINRKLB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹1.

Latest statistics put total assets at ₹1 and shareholder funds at ₹-1.

Screen Rekvina Laboratories income statement and profit fundamentals. Analyze VINRKLB quarterly results. Rekvina Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹2 and net profit was ₹0, equal to earnings per unit of ₹-0.50, at an operating margin of -19%.

In that period expenses were ₹2, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹1 and net profit of ₹0.

Screen VINRKLB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹1.

Over the same period, investing activities provided ₹0 and financing activities provided ₹1.

See Rekvina Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Rekvina Laboratories promoter holding and ownership changes for VINRKLB on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 41.30%, foreign institutions 0.00%, domestic institutions 0.00% and the public 45.88%, spread across 2,475 shareholders.

The shareholder count was 2,475 in 2026-Mar, compared with 2,465 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Rekvina Laboratories. Rekvina Laboratories dividend yield can be compared with peers and other stocks in the market.

See which indices include Rekvina Laboratories stock. Check VINRKLB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Rekvina Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Rekvina Laboratories stock events that may affect VINRKLB share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.

It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 21, 2026.

Screen VINRKLB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen VINRKLB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 1, 2026.

The next most recent announcements are dated October 1, 2026 and September 26, 2026.

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 12 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.